Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF Plus Anthracycline in Platinum-resistant Ovarian Cancer
NCT03804866Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Mar 2013
- Primary completion
- Dec 2016
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of NGR-TNF in ovarian cancer, sponsored by AGC Biologics. Started Mar 2013; status: completed.
02
Drugs
NGR-TNF
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03804866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804866.